Ovid Therapeutics Inc. (OVID) Profit Margins
Over the twelve months to 2026-06-30, Ovid Therapeutics Inc. (OVID) had operating margin -3686.7%, net margin -2178.9%, free cash flow margin -3460.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OVIDOvid Therapeutics Inc.Follow OVID — free
—
Price chart with a free account
- Market cap
- 421.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -645.4% | 59.6% | -3696.4% | -15122.7% | -10933.7% | -585.2% | -3686.7% | |
| Net margin | -642.3% | 58.9% | -3604.7% | -13351.8% | -4670.1% | -240.1% | -2178.9% | |
| FCF margin | -411.9% | 56.8% | -3769.5% | -11713.8% | -9914.7% | -528.6% | -3460.1% |
USD millions · SEC XBRL
Ovid Therapeutics Inc. — questions
- What is Ovid Therapeutics Inc.'s operating margin?
- -3686.7% over the twelve months to 2026-06-30.
- What is Ovid Therapeutics Inc.'s net profit margin?
- -2178.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Ovid Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.